As the immune resetting field surges in 2026, industry leaders are convening at the inaugural Immune Resetting: B-Cell Mediated & Beyond Summit.
This meeting will bring together Senior Medical Directors, SVPs of Research, Chief Medical Officers, Heads of Immunology, Executive Directors, and CEOs, all actively evaluating, advancing, and investing in immune‑resetting strategies across autoimmunity, inflammation, and cell therapy.
50+ Industry Leaders
18+ World Class Speakers
5 Modalities Covered
6+ Hours of Unparalleled Networking
2 Deep Dive Workshops
Companies in the Room Include:
Representatives From:
- Abbvie
- Artiva Biotherapeutics
- AstraZeneca
- Biogen
- Bristol Myers Squibb
- Cabaletta Bio
- Cullian Therapeutics
- GentiBio
- Hinge Bio, Inc.
- Innovent Biologics
- Kali Therapeutics
- Kite Pharma
- Marengo Therapeutics
- Moderna
- ModeX Therapeutics
- Numab Therapeutics
- Oblenio Bio
- Ouro Medicines
- Olethros B.V.
- Orum Therapeutics
- Pfizer
- Rise Therapeutics
- Sail Biomedicines
- University of Pittsburgh
- UCB
- UCP Biosciences
- VelaVigoutics
Job Titles Include:
- Project Director Immunology
- Senior Medical Director, Neuro Clinical Development
- Senior Vice President - Research & Early Development
- Executive Director, Translational Science Lead, Immunology Cell Therapy
- Associate Scientific Director, Immunology Engineering & Technical
- Director, Clinical Development
- Principal Scientist
- Chief Medical Officer
- Vice President - Translational Research
- Chief Scientific Officer
- Senior Director, Preclinical Development
- Associate Director
- Director, Discovery Biology Engineering & Technical
- Chief Executive Officer & Director
- Principal Scientist Immuno-Oncology
- Group Leader Translational Science
- Senior Director, Translational Biology Nonclinical Development
- Chief Scientific Officer
- Chief Executive Officer
- Associate Director Immunology
- Senior Principal Computational Geneticist I&I
- Senior Vice President - Research
- Vice President, Immunology Medical & Health
- Distinguished Professor
- Immunology Partnering Lead
- Physician-scientist Translational Medicine
- Founder & Chief Executive Officer
Explore the Brand-New Agenda
Hear the latest industry breakthroughs in B-cell mechanistic understanding and gain exclusive modality and platform insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself as the go-to service provider of the rapidly progressing ‘Immune Resetting’ landscape to ensure your brand is at the heart of deals in this evolving space.
Join Biopharma Experts
Be part of the most critical conversations shaping the future of autoimmune therapy. Connect with like-minded experts across every stage of drug development, from discovery to clinical application, and dive into focused discussions on redefining immune reset.